OA12845A - Single dose azithromycin for treating respiratory infections. - Google Patents

Single dose azithromycin for treating respiratory infections. Download PDF

Info

Publication number
OA12845A
OA12845A OA1200400048A OA1200400048A OA12845A OA 12845 A OA12845 A OA 12845A OA 1200400048 A OA1200400048 A OA 1200400048A OA 1200400048 A OA1200400048 A OA 1200400048A OA 12845 A OA12845 A OA 12845A
Authority
OA
OAPI
Prior art keywords
dose
pharmaceutical composition
azithromycin
single dose
human
Prior art date
Application number
OA1200400048A
Other languages
English (en)
Inventor
Michael William Dunne
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of OA12845A publication Critical patent/OA12845A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
OA1200400048A 2001-08-21 2002-07-31 Single dose azithromycin for treating respiratory infections. OA12845A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31386701P 2001-08-21 2001-08-21

Publications (1)

Publication Number Publication Date
OA12845A true OA12845A (en) 2006-09-15

Family

ID=23217490

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200400048A OA12845A (en) 2001-08-21 2002-07-31 Single dose azithromycin for treating respiratory infections.

Country Status (25)

Country Link
US (3) US20030148964A1 (fr)
EP (1) EP1418924A2 (fr)
JP (1) JP2005501862A (fr)
KR (1) KR20040032942A (fr)
AP (1) AP1729A (fr)
BG (1) BG108537A (fr)
BR (1) BR0211830A (fr)
CA (1) CA2458135A1 (fr)
CZ (1) CZ2004232A3 (fr)
EA (1) EA200400214A1 (fr)
EC (1) ECSP044985A (fr)
GE (1) GEP20063812B (fr)
HR (1) HRP20040163A2 (fr)
HU (1) HUP0401332A2 (fr)
IL (1) IL159585A0 (fr)
IS (1) IS7092A (fr)
MA (1) MA27059A1 (fr)
MX (1) MXPA04001605A (fr)
OA (1) OA12845A (fr)
PL (1) PL367888A1 (fr)
SK (1) SK1012004A3 (fr)
TN (1) TNSN04035A1 (fr)
WO (1) WO2003018031A2 (fr)
YU (1) YU8804A (fr)
ZA (1) ZA200400804B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE421882T1 (de) * 2003-07-24 2009-02-15 Pliva Hrvatska D O O Schnellösliches azithromycin in einzeldosisform
ATE399536T1 (de) 2003-12-04 2008-07-15 Pfizer Prod Inc Verfahren zur herstellung von pharmazeutischen multiteilchenförmigen produkten
BRPI0416534A (pt) 2003-12-04 2007-01-09 Pfizer Prod Inc composições multiparticuladas com estabilidade melhorada
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
US8226975B2 (en) 2005-12-08 2012-07-24 Insmed Incorporated Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US20090005326A1 (en) * 2007-06-26 2009-01-01 Idexx Laboratories, Inc. Single dose roxithromycin
US20090197956A1 (en) * 2008-02-04 2009-08-06 Arbor Pharmaceuticals, Inc. Treatment of acute otitis media with xylitol and n-acetylcysteine
US20110105421A1 (en) * 2008-03-14 2011-05-05 The Florida International University Board Of Trustees Ellagitannins as inhibitors of bacterial quorum sensing
CA2838188C (fr) 2011-06-04 2017-04-18 Rochester General Hospital Research Institute Compositions et procedes associes a la proteine p6 de l'haemophilus influenzae
ES2743039T3 (es) 2012-11-29 2020-02-18 Insmed Inc Formulaciones de vancomicina estabilizada
SI3142643T1 (sl) 2014-05-15 2019-11-29 Insmed Inc Postopki za zdravljenje pljučnih netuberkuloznih mikobakterijskih infekcij
US11571386B2 (en) 2018-03-30 2023-02-07 Insmed Incorporated Methods for continuous manufacture of liposomal drug products
WO2021163451A1 (fr) * 2020-02-14 2021-08-19 Asklepios Biopharmaceutical, Inc. Procédé de traitement d'une toxicité associée à une thérapie génique avec des antibiotiques

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US53264A (en) * 1866-03-20 Improved ditching-machine
YU43116B (en) 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
SI8110592A8 (en) 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
RU2066324C1 (ru) 1987-07-09 1996-09-10 Пфайзер Инк. Кристаллический дигидрат азитромицина и способ его получения
WO1989002271A1 (fr) 1987-09-10 1989-03-23 Pfizer Azithromycine et derives utilises comme agents anti-protozoaires
YU45590A (sh) 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
TW271400B (fr) 1992-07-30 1996-03-01 Pfizer
CA2162401C (fr) 1993-05-19 1998-11-03 Bingwei V. Yang Produit intermedaire pour l'azithromycine
US5605889A (en) 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
CN1096862C (zh) 1994-05-06 2002-12-25 辉瑞大药厂 阿齐霉素的控释剂型
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US20040053264A1 (en) * 2002-02-01 2004-03-18 Park Sung Sup Clinical panel assay using DNA chips

Also Published As

Publication number Publication date
US20030148964A1 (en) 2003-08-07
ZA200400804B (en) 2005-05-03
IS7092A (is) 2003-12-23
US20050250712A1 (en) 2005-11-10
US6987093B2 (en) 2006-01-17
EP1418924A2 (fr) 2004-05-19
EA200400214A1 (ru) 2004-06-24
CA2458135A1 (fr) 2003-03-06
HRP20040163A2 (en) 2005-02-28
SK1012004A3 (sk) 2005-04-01
HUP0401332A2 (hu) 2004-11-29
BR0211830A (pt) 2004-09-08
JP2005501862A (ja) 2005-01-20
PL367888A1 (en) 2005-03-07
WO2003018031A3 (fr) 2003-10-02
WO2003018031A2 (fr) 2003-03-06
MA27059A1 (fr) 2004-12-20
US20040023898A1 (en) 2004-02-05
ECSP044985A (es) 2004-04-28
IL159585A0 (en) 2004-06-01
BG108537A (bg) 2005-02-28
AP1729A (en) 2007-03-26
TNSN04035A1 (fr) 2006-06-01
MXPA04001605A (es) 2004-07-08
KR20040032942A (ko) 2004-04-17
AP2004002968A0 (en) 2004-03-31
US7067493B2 (en) 2006-06-27
CZ2004232A3 (cs) 2005-10-12
GEP20063812B (en) 2006-05-10
YU8804A (sh) 2006-08-17

Similar Documents

Publication Publication Date Title
Barry et al. Intravenous immunoglobulin therapy for toxic shock syndrome
OA12845A (en) Single dose azithromycin for treating respiratory infections.
JP2010511039A5 (fr)
JP2002523437A5 (fr)
Marchi Comparative efficacy and tolerability of clarithromycin and amoxycillin in the treatment of out-patients with acute maxillary sinusitis
Dunne et al. A phase 1 study to assess the pharmacokinetics of sulopenem etzadroxil (PF-03709270)
US20060210483A1 (en) Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections
Decker et al. Respiratory arrest in myasthenia gravis with colistimethate therapy
Kavi et al. A comparison of the pharmacokinetics and tissue penetration of spiramycin and erythromycin
US20060142254A1 (en) Antipyretic preparation containing xylitol
AU2002313574A1 (en) Single dose azithromycin for treating respiratory infections
CN114375200A (zh) 治疗传染病的药物和方法
Kafetzis et al. Efficacy and safety of roxithromycin in treating paediatric patients. A European multicentre study
Randolph Clinical comparison of once-daily cefadroxil and thrice-daily cefaclor in the treatment of streptococcal pharyngitis
AkŞÍT et al. Seasonal benzathine penicillin G prophylaxis for recurrent streptococcal pharyngitis in children
RU2498803C1 (ru) Противотуберкулезное лекарственное средство
CA2120917A1 (fr) Preparation externe pour le traitement des hemorroides
US20060057133A1 (en) Topical pathogenic-tissue-destroying liquid
Fiese Therapy of coccidioidomycosis
RU2180532C2 (ru) Способ лечения папилломатоза
CA2199255A1 (fr) Vaccin contre des infections vaginales s'administrant par voie enterique
RU2333766C2 (ru) Способы введения далбаванцина для лечения бактериальных инфекций
DuPont Overview of clinical experience of pefloxacin in gastrointestinal infections
JM et al. Streptomycin and dihydrostreptomycin.
Keshavan et al. Penetration of Doxycycline into the Aqueous Humor from Blood